While ICAM-1 levels and its polymorphisms appear linked to the development of nephropathy, the levels of modified LDL in IC and the levels of fibroblast growth factor have predictive value for cardiovascular disease in type 1 and type 2 diabetes. Here, ICAM1 is linked to type 2 diabetes mellitus.